Eddy C. Agbo, DVM, PhD
Chairman and CEO
Dr. Agbo is responsible for guiding the strategic management and scientific direction of Fyodor. Prior to founding Fyodor, Dr. Agbo held a senior management position as the Senior Director for Research and Preclinical Development at Cangen Biotechnologies, Inc, a cancer diagnostics and therapeutics company based in Baltimore MD, where he functioned as the Chief Technical Lead and directed Cangen’s pivotal bladder and lung cancer diagnostic and therapeutic programs. Prior to joining Cangen, Dr. Agbo was a Research Fellow at Johns Hopkins University School of Medicine, where he worked on diagnostic and therapeutic biomarker discovery. Formerly, he held biomedical research and product development industry and university positions at ID-Lelystad, Utrecht University, Wageningen University and Free University Amsterdam, all in the Netherlands (Holland). At ID-Lelystad, he undertook the development and validation of an ELISA-based diagnostic test kit for a protozoan parasite. ssim urna vitae enim pretium vel aliquam metus volutpat.
Dr. Agbo has over 15 years of biomedical research and direct product development experience in university and industry settings. He is the lead inventor on pending genotyping and diagnostic biomarker patents, and author of numerous scientific publications in peer reviewed journals, including Science, Nature, Transactions of the Biochemical Society UK, Trends in Parasitology, Trends in Microbiology, Parasitology, Experimental Parasitology and Chromosoma.
Dr. Agbo earned his PhD in Molecular Genetics from Utrecht University, MS in Biotechnology from Wageningen University, both in The Netherlands, and Doctor of Veterinary Medicine (DVM) degree from the University of Ibadan, Nigeria. Dr. Agbo holds a graduate certificate in Leadership and Management in the Life Sciences from Johns Hopkins University Business School.
Anne M Derrick, MBA
Vice President, Business Development and Operations
Ms. Derrick has extensive experience in the development and commercialization of both diagnostic and biotechnology products. She has been providing business development support to biotech companies for the past 10 years, including at Guilford Pharmaceuticals, MGI Pharma and most recently at Cangen Corporation. Previously, she held positions in diagnostic product research and development, biotech sales and marketing with biotech companies in both the diagnostic and therapeutic product areas. She has experience in licensing, strategic planning, product development and intellectual property strategy.
Ms. Derrick received a B.S. in Medical Technology from St Francis University and a Masters in Business Administration from the University of Maryland University College.
Dr. Victoria Enwemadu, Pharm D.
Global Head of Projects
Dr. Victoria Enwemadu Pharm D. is responsible for the leadership and support of various projects which facilitate the manufacturing, registration, launch, and commercialization activities of Fyodor’s molecular diagnostic products for emerging and developing markets.
Dr. Enwemadu has over 15 years combined experience in the pharmaceutical, hospital and retail sectors including project management, literature analysis, medical communications and management of scientific publication activities. Prior to joining the Fyodor team, Dr. Enwemadu, served as a Senior Publication Manager at Merck in several therapeutic areas such as HIV, hepatitis C and fungal infections.
Dr. Enwemadu received her Pharm D. from the University of Florida and a Bachelor of Science in pharmacy from Rutgers College of Pharmacy. Dr. Enwemadu is a member of the American Pharmacists Association and Nigerian Association of Pharmacists and Pharmaceutical Scientists
Eddy C. Agbo, DVM, PhD
Chairman and CEO
Dr. Agbo has extensive senior management experience in biomedical research & product development in both university and industry settings. Prior to founding Fyodor, he was a Senior Director for Research and Preclinical Development at Cangen Biotechnologies Corporation, where he functioned as the Chief Technical Lead and directed Cangen’s pivotal bladder and lung cancer diagnostic and therapeutic programs. Earlier, Dr. Agbo held top-level research positions at Johns Hopkins University School of Medicine, Baltimore, Maryland, and at ID-Lelystad, Utrecht University, Wageningen University and Free University Amsterdam, all in the Netherlands. He is the lead inventor on pending genotyping and diagnostic biomarker patents, and author of numerous leading-edge scientific publications in topmost scientific journals, including Science, Nature, Transactions of the Biochemical Society UK, Trends in Parasitology, Trends in Microbiology, among others. Dr. Agbo earned his PhD in Molecular Genetics from Utrecht University, MS in Biotechnology from Wageningen University, both in The Netherlands, Doctor of Veterinary Medicine (DVM) degree from the University of Ibadan, Nigeria, and holds a Graduate Certificate in Leadership and Management in the Life Sciences from Johns Hopkins University Business School. He is a member of Baltimore Business Roundtable and the Greater Baltimore Committee Bioscience Strategy sub-Committee. He was nominated for the prestigious Greater Baltimore Committee “Entrepreneur of the Year Award” in 2010, and recently profiled in The Business Monthly Magazine, and in CEO Magazine.
Major General (Ret.) Roger R. Blunt, P.E., MS, PhD
Dr Blunt is the President and Managing Member of Essex Construction LLC. He is a Civil Engineer, a Nuclear Engineer, registered professionally in the District of Columbia. A West Point graduate, he holds Masters degrees in Nuclear Engineering from the Massachusetts Institute of Technology and a Doctor of Public Service degree from the University of Maryland Eastern Shore. After an active career in the U.S Army Corps of Engineers that included an assignment on the faculty of the United States Military Academy, Major General Blunt continued his service in the Active Army Reserves until his retirement. He has held prior positions as Director of the Potomac Electric Power Company and the Ameritas-Acacia Mutual Holding Company. He is a past Chairman of the Association of Governing Boards of Universities and Colleges, and served as Vice Chairman of the University System of Maryland Board of Regents. He is a former Director of the Maryland Chamber of Commerce, serves on the Board of Directors of the University of Maryland Foundation and a member of Greater Prince George’s County Business Roundtable. Dr Blunt is the Past Chairman and President of the Pan-African Health Foundation USA, whose Nigerian affiliate built a $20 million auto-disable single-use syringe plant with an annual production capacity of 60 million syringes in River State.
Over the years, he has consulted or participated in economic development activities involving facility design, guidelines for sustainable development, housing, commercial construction and rural farm-to-market roads in several African countries. Roger Blunt is a 2001 laureate of the Washington Business Hall of Fame, received the 2003 Hall of Fame of the American Minority Contractors and Business Association, a recipient of the Parren J. Mitchell Foundation’s Lifetime Achievement Award in 2004, and was inducted into the Maryland Chamber of Commerce Business Hall of Fame in 2006.
John T. Dahldorf
John T. Dahldorf is the Chief Financial Officer at Acutus Medical. Mr. Dahldorf has more than 30 years of financial, operational and leadership experience in the healthcare industry including extensive experience in acquisitions and integration, and the development and execution of strategic plans. From July 2003 to February of 2015, Mr. Dahldorf served as the Chief Financial Officer of Volcano Corporation, an interventional cardiology medical device company. From March 2002 to December 2002, Mr. Dahldorf served as Co-Chief Executive Officer of Digirad Corporation, a medical imaging company, where he also served as the Chief Financial Officer from November 2001 to December 2002. From March 1999 to November 2001, Mr. Dahldorf served as the Finance Director of Arrow Electronics, Inc., a distributor of electronic components and computer products. From 1981 to March of 1999, Mr. Dahldorf held various financial and operational positions at Baxter Healthcare. Mr. Dahldorf holds a B.B. in Finance and an M.B.A. from Western Illinois University.
Dr. Joe O’Neill, MD, MPH
Dr. O’Neill is the Director of the University of Maryland Global Health Initiatives Program and a Visiting Professor in the School of Medicine, where he currently oversees over $100 million portfolio of projects being conducted by University teams in 25 nations around the world. He is a board certified internist with extensive clinical, leadership and management skills. He was the only physician on the White House Domestic Policy Council during the first term of the George W. Bush administration and was intimately involved in all health related issues that reached that level of policy review. He was credited by the President as having been the ”architect” of the President’s Emergency Plan for AIDS Relief (PEPFAR) – the largest global health initiative in history. He has held other senior management and policy roles in the Clinton and Bush administrations including the $31 billion Health and Human Services HIV/AIDS portfolio (overseeing NIH, FDA and other relevant agencies); the Ryan White CARE Act programs; the National Organ Transplant Program and Bone Marrow Registry; the National Tele-Medicine initiative for the Department of Health and Human Services, among others.
Dr. O’Neill has many years of experience on the faculty of the School of Medicine at Johns Hopkins University and is currently on the faculty of the University of Maryland School of Medicine. He serves on advisory or director boards of several foundations. He is an accomplished public speaker, has edited a medical textbook, published scholarly articles, and has appeared on ABC Nightline, PBS’s News Hour and other venues.
Dr. Basil Onugu, MBA, PhD
Dr. Onugu serves as a director on the Board of Fyodor Biotechnologies. Dr. Onugu has extensive experience in banking and financial management, international trade, manpower development and resources and treasury management. He is the Managing Director of Leadership Paradigm Powerhouse Ltd, an organizational development company dedicated to transforming individuals and organizations. Dr. Onugu has over 22 years experience in the banking and finance industry, rising to the Managing Director/Chief Executive position of a commercial bank in Nigeria in 2000. In this position, he restructured and turned a moribund commercial bank to profitability and over 1.5 billion naira (US $ 37.5 million) capitalization within two years. He co-authored an acclaimed book – “The Craft of Credit Creation” – widely used in the banking industry. Prior to joining the banking industry in 1984, Dr. Onugu had extensive training in Management Consulting at the Centre for Management Development where he worked as a Trainee Management Consultant for 4 years, under the tutelage of ILO and UNDP experts. Upon retiring from the banking industry, he set up a Management Consulting organization which enables him not only to apply the wealth of experience he has garnered over the years, but also to impart knowledge and skills to current industry practitioners.
Dr. Onugu holds a PhD in Management, an MBA from Sloan School of Management, Massachusetts Institute of Technology (MIT), Cambridge USA, and a BSc in Mathematics from University of Nigeria, Nsukka. He also holds a Diploma in Economics from the Economics Institute, University of Colorado, Denver, USA, a Diploma in Banking & Development Finance from Manchester Business School, UK, a Diploma in Business Administration from Ahmadu Bello University, Zaria, Nigeria, and a certificate in Leadership from Resource Associates Corporation (RAC), Pennsylvania, USA.